Monitoring of (Leukemia-Specific) Immune Cells in Stages, Treatment Groups and in the Course of Disease and Therapy Contributes to Qualify Antileukemic Potential and Survival in Patients with AML
在疾病的不同阶段、治疗组别以及疾病和治疗过程中监测(白血病特异性)免疫细胞有助于评估急性髓系白血病(AML)患者的抗白血病潜力和生存率。
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms262110336
Stein, Julian; Anand, Philipp; Abdulmajid, Joudi; Hartz, Anne; Unterfrauner, Marianne; Feng, Xiaojia; Schmieder, Nicolas; Kruk, Linus; Bojko, Peter; Schmohl, Joerg; Schmid, Christoph; Filippini Velázquez, Giuliano; Schmetzer, Helga M